3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
77
Leukemia
74
Leukemia, Lymphocytic, Chronic, B-Cell
68
Myelodysplastic Syndromes
56
Lymphoma
49
Precursor Cell Lymphoblastic Leukemia-Lymphoma
47
Lymphoma, Non-Hodgkin
45
Multiple Myeloma
43
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
38
Hodgkin Disease
36
Melanoma
25
Hematologic Neoplasms
25
Recurrence
19
Neoplasms
17
Myeloproliferative Disorders
17
Neoplasm Metastasis
15
Lymphoma, Follicular
15
Primary Myelofibrosis
14
Neoplasms, Plasma Cell
14
Lymphoma, Large B-Cell, Diffuse
14
Lymphoma, Mantle-Cell
13
Skin Neoplasms
11
Graft vs Host Disease
11
Burkitt Lymphoma
11
Anemia, Refractory, with Excess of Blasts
11
Lymphoma, B-Cell, Marginal Zone
10
Lymphoma, B-Cell
10
Leukemia, Myelomonocytic, Chronic
9
Hematologic Diseases
8
Breast Neoplasms
8
Interventions
Temozolomide
7
Magnetic Resonance Spectroscopy
7
X-Rays
5
Phantoms, Imaging
5
Bevacizumab
5
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Carboplatin
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
Vemurafenib
2
Lapatinib
2
LY3023414
2
Everolimus
2
Etoposide
2
Erlotinib Hydrochloride
2
veliparib
1
pomalidomide
1
poly ICLC
1
picropodophyllin
1
marizomib
1
imetelstat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ependymoma
×
fludarabine
×
Clear all
No trials found.